Nidaa A Ababneh Selected Research

Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)

7/2020

Establishment of (JUCTCi007-A) iPSC line from a patient with congenital myasthenic syndrome (CMS) carrying a homozygous mutation p.Arg331Trp (c.991C > T) in the CHRNE gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nidaa A Ababneh Research Topics

Disease

4	Neoplasms (Cancer) 01/2024 - 12/2020
3	COVID-19 08/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2023
1	Adenocarcinoma of Lung 01/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024
1	Adenocarcinoma 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Human Influenza (Influenza) 08/2022
1	Tonsillitis 01/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Infertility (Sterility) 01/2021
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 07/2020
1	Hypersensitivity (Allergy) 01/2020
1	Cerebellar Ataxia (Dysmetria) 01/2020
1	Infections 01/2019

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 08/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2023
2	Etoposide (VP 16)FDA LinkGeneric 01/2024 - 01/2020
2	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2022 - 01/2021
1	Complement System Proteins (Complement)IBA 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	PhytochemicalsIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	SenotherapeuticsIBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2022
1	COVID-19 VaccinesIBA 01/2021
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 12/2020
1	Cholinergic ReceptorsIBA 07/2020
1	Therapeutic UsesIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020

Therapy/Procedure

4	Therapeutics 01/2024 - 01/2019
2	Neoadjuvant Therapy 01/2024 - 01/2023